The Minister of Health Carolina Darias visits the facilities of the Zendal Group

vacuna covid 19 de novavax se fabricará en Biofabri del Grupo Zendal

  • • Darias expects the Novavax vaccine to receive authorization “from April”.

Porriño, 25th of February 2021.-The Minister of Health Carolina Darias has highlighted the importance for Spain, both in the European and international context, to be able to carry out the complete manufacturing process of the COVID-19 Novavax vaccine thanks to the facilities of the Zendal Group. This is how she has exposed it during her visit to the biotechnology group in which she underlined the “very good results” obtained by this vaccine in phase 3 clinical trials. She described them as “encouraging”, even with some new variants, such as the South African.

The minister wanted to convey to the persons in charge the “boost and support” of the Government of Spain and she thanked the Galician Group for its “essential” work in this pandemic, but also for its commitment to “high quality employment.”

Zendal will manufacture the antigen for Novavax doses for the European Union and has also an agreement with the Coalition for the Promotion of Innovations for Epidemic Preparedness (CEPI) for the filling and finishing of more than 500 million doses of vaccines.